New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin

被引：19
作者：
Bostan, Ecem [1 ]
Yel, Beril [1 ]
Akdogan, Neslihan [1 ]
Gokoz, Ozay [2 ]
机构：
[1] Hacettepe Univ, Fac Med, Dept Dermatol & Venereol, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Pathol, Ankara, Turkey
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 02期
关键词：
D O I：
10.1111/dth.15241
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 8 条
  • [1] Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature
    Annabi, E.
    Dupin, N.
    Sohier, P.
    Garel, B.
    Franck, N.
    Aractingi, S.
    Guegan, S.
    Oules, B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (12) : E847 - E850
  • [2] Nassar, 2021, J INFECT PUBLIC HEAL, P187
  • [3] Dipeptidyl peptidase IV inhibitor-associated bullous pemphigoid: a recently recognized autoimmune blistering disease with unique clinical, immunological and genetic characteristics
    Nishie, Wataru
    [J]. IMMUNOLOGICAL MEDICINE, 2019, 42 (01) : 22 - 28
  • [4] Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population
    Plaquevent, Marthe
    Tetart, Florence
    Fardet, Laurence
    Ingen-Housz-Oro, Saskia
    Valeyrie-Allanore, Laurence
    Bernard, Philippe
    Hebert, Vivien
    Roussel, Aude
    Avenel-Audran, Martine
    Chaby, Guillaume
    D'Incan, Michel
    Ferrier-Le-Bouedec, Marie-Christine
    Duvert-Lehembre, Sophie
    Picard-Dahan, Catherine
    Jeudy, Geraldine
    Collet, Evelyne
    Labeille, Bruno
    Morice, Cecile
    Richard, Marie-Aleth
    Bourgault-Villada, Isabelle
    Litrowski, Noemie
    Bara, Corina
    Mahe, Emmanuel
    Prost-Squarcioni, Catherine
    Alexandre, Marina
    Quereux, Gaelle
    Bernier, Claire
    Soria, Angele
    Thomas-Beaulieu, Domitille
    Pauwels, Christine
    Dereure, Olivier
    Benichou, Jacques
    Joly, Pascal
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (04) : 835 - 841
  • [5] Drug-induced pemphigoid: a review of the literature
    Stavropoulos, P. G.
    Soura, E.
    Antoniou, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (09) : 1133 - 1140
  • [6] Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients
    Thewjitcharoen, Yotsapon
    Wanothayaroj, Ekgaluck
    Thammawiwat, Chattip
    Porramatikul, Sriurai
    Vorayingyong, Chuleekorn
    Nakasatien, Soontaree
    Krittiyawong, Sirinate
    Chanprapaph, Kumutnart
    Himathongkam, Thep
    [J]. CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [7] Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination
    Tomayko, Mary M.
    Damsky, William
    Fathy, Ramie
    McMahon, Devon E.
    Turner, Noel
    Valentin, Monica N.
    Rallis, Tena
    Aivaz, Ohara
    Fox, Lindy P.
    Freeman, Esther E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (03) : 750 - 751
  • [8] Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid
    Walmsley, Natasha
    Hampton, Philip
    [J]. JOURNAL OF DERMATOLOGICAL CASE REPORTS, 2011, 5 (04): : 74 - 76
1